UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ( Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission File No. 001-36297 Revance Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 77-0551645 (I.R.S. Employer Id ...

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2020 Earnings Conference Call February 22, 2021 4:30 PM ET Company Participants Jessica Serra - Head of Investor Relations and ESG Mark Foley - President and Chief Executive Officer Toby Schilke - Chief Financial Officer Roman Rubio - Senior Vice President Clinical Development Dustin Sjuts - Chief Commercial Officer, Therapeutics & Aesthetics Abhay Joshi - Chief Operating Officer and President of R&D and Product Operation Conference Call Participants Ken Cacciator ...

| --- | --- | --- | |---------------------------------------------------------|-------|-------| | | | | | | | | | Daring To Make A Difference Daring To Make A Difference | | | | COMPANY PRESENTATION NOVEMBER 2020 | | | Forward-Looking Statements Safe Harbor / Market Data 2 This presentation contains forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to: financial metrics and outlook; the market ...

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q3 2020 Earnings Conference Call November 9, 2020 4:30 PM ET Company Participants Jeanie Herbert - Head of Investor Relations Mark Foley - President & Chief Executive Officer Toby Schilke - Chief Financial Officer Dustin Sjuts - Chief Commercial Officer, Therapeutics & Aesthetics Conference Call Participants Ken Cacciatore - Cowen & Company Annabel Samimy - Stifel Terence Flynn - Goldman Sachs David Amsellem - Piper Sandler Kush Patel - Guggenheim Tim Lugo - William ...

Daring To Make A Difference COMPANY PRESENTATION September 2020 Prevance FORWARD-LOOKING STATEMENTS / SAFE HARBOR / MARKET DATA This presentation contains forward-looking statements, including forward-statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to: financial metrics and outlook; the growth of markets for global neuromodulators, dermal fillers and aesthetics fintech platforms; the process and timing of, and ability to complete, current and an ...

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Jeanie Herbert - Head, Investor Relations & Corporate Communications Mark Foley - President & Chief Executive Officer Dustin Sjuts - Chief Commercial Officer, Aesthetics & Therapeutics Toby Schilke - Chief Financial Officer Abhay Joshi - Chief Operating Officer & President of R&D & Product Operations Conference Call Participants Terence Flynn - Goldman Sachs Stacy Ku - Cowen & Company Dav ...

| --- | --- | --- | |--------------------------------|-------|-------| | | | | | | | | | | | | | Daring To Make A Difference | | | | COMPANY PRESENTATION JUNE 2020 | | | This presentation contains forward-looking statements, including forward-statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to: financial metrics and outlook; the process and timing of, and ability to complete, current and anticipated future clinical development of our investigatio ...

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Jeanie Herbert - Senior Director of Investor Relations and Corporate Communications Mark Foley - President and Chief Executive Officer Toby Schilke - Chief Financial Officer Dr. Abhay Joshi - Chief Operating Officer and President of R&D and Product Operations Dustin Sjuts - Chief Commercial Officer of Aesthetics and Therapeutics Conference Call Participants Jacob Hughes - Wells Fargo Securit ...

1 Daring to Make a Difference Company Presentation March 2020 『·revance Forward-Looking Statements / Safe Harbor / Market Data 2 This presentation contains forward-looking statements, including forward-statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to: financial metrics and outlook; the process and timing of, and ability to complete, current and anticipated future clinical development of our investigational product candidates, including anticip ...

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2019 Results Earnings Conference Call February 24, 2020 4:30 AM ET Company Participants Jeanie Herbert - Senior Director of Investor Relations and Corporate Communications Mark Foley - President, Chief Executive Officer Dustin Sjuts - Chief Commercial Officer of Aesthetics & Therapeutics Toby Schilke - Chief Financial Officer Abhay Joshi - Chief Operating Officer, President of R&D and Product Operations Conference Call Participants Annabel Samimy - Stifel Ken Cacc ...